Artemis Medicare Services Ltd
Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the promoters of the Apollo Tyres Group, is engaged in healthcare business. AMSL operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. The specialty areas for AMSL include Orthopaedics, Oncology, Cardiovascular, Neurosciences and Bariatric & Minimally Invasive Surgery. ASML has been awarded with the NABH and JCI accreditation. AMSL has also diversified its presence through Artemis Daffodil , Artemis Lite, Artemis Cardiac Care and Artemis Solace models. [1][2]
- Market Cap ₹ 3,528 Cr.
- Current Price ₹ 254
- High / Low ₹ 350 / 175
- Stock P/E 42.9
- Book Value ₹ 60.9
- Dividend Yield 0.18 %
- ROCE 14.6 %
- ROE 12.8 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 33.3% CAGR over last 5 years
Cons
- Stock is trading at 4.17 times its book value
- Company has a low return on equity of 11.6% over last 3 years.
- Promoters have pledged 44.5% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
547 | 565 | 408 | 555 | 737 | 879 | 937 | |
481 | 503 | 373 | 487 | 643 | 746 | 785 | |
Operating Profit | 66 | 62 | 35 | 68 | 94 | 133 | 152 |
OPM % | 12% | 11% | 9% | 12% | 13% | 15% | 16% |
2 | 4 | 7 | 3 | 7 | 7 | 33 | |
Interest | 11 | 13 | 13 | 12 | 20 | 31 | 32 |
Depreciation | 20 | 23 | 22 | 22 | 31 | 40 | 45 |
Profit before tax | 37 | 31 | 8 | 37 | 51 | 68 | 108 |
Tax % | 45% | 36% | 18% | 16% | 25% | 28% | 24% |
20 | 19 | 6 | 31 | 38 | 49 | 82 | |
EPS in Rs | 0.97 | 1.49 | 0.49 | 2.40 | 2.88 | 3.62 | 6.00 |
Dividend Payout % | 0% | 0% | 0% | 0% | 16% | 12% | 7% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 19% |
TTM: | 7% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 37% |
TTM: | 68% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 70% |
3 Years: | 83% |
1 Year: | 43% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 12% |
Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Equity Capital | 13 | 13 | 13 | 13 | 13 | 14 | 14 |
Reserves | 280 | 300 | 307 | 346 | 390 | 435 | 824 |
114 | 113 | 147 | 201 | 286 | 320 | 290 | |
147 | 160 | 133 | 149 | 216 | 203 | 229 | |
Total Liabilities | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 |
381 | 393 | 383 | 489 | 605 | 719 | 746 | |
CWIP | 49 | 56 | 81 | 64 | 95 | 33 | 39 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
124 | 137 | 136 | 157 | 205 | 219 | 572 | |
Total Assets | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
40 | 56 | 27 | 60 | 127 | 109 | 146 | |
-50 | -26 | -37 | -107 | -158 | -87 | -385 | |
14 | -27 | 18 | 44 | 38 | -30 | 267 | |
Net Cash Flow | 5 | 2 | 8 | -3 | 7 | -8 | 27 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Debtor Days | 52 | 49 | 49 | 48 | 46 | 39 | 39 |
Inventory Days | |||||||
Days Payable | |||||||
Cash Conversion Cycle | 52 | 49 | 49 | 48 | 46 | 39 | 39 |
Working Capital Days | -26 | -28 | -16 | -9 | -26 | -13 | -12 |
ROCE % | 10% | 4% | 10% | 11% | 14% | 15% |
Documents
Announcements
-
Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
2d - Dividend of Re.0.45/share for FY25 with detailed TDS tax deduction guidelines for shareholders.
- Closure of Trading Window 25 Jun
- Record Date For Payment Of Final Dividend 20 Jun
- Intimation Of Annual General Meeting 20 Jun
-
Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
17 Jun - Reminder to physical shareholders to submit PAN, KYC, nomination details per SEBI mandate.
Annual reports
Concalls
-
May 2025TranscriptNotesPPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024TranscriptNotesPPT
-
Aug 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
Geographical Revenue Break-up 9MFY24:[1]
Domestic : ~76%
Outside India : ~24%